20/09/2025
In a recent Forbes article, our CEO, Naser Al Yammahi, addressed a pressing issue: declining global health funding and its impact on Africa’s healthcare systems.
With rapid population growth, rising disease burdens, and infrastructure gaps, the challenge is clear — how can Africa’s healthcare not only survive but thrive with reduced international support?
His message is powerful: the future depends on stronger public-private partnerships, deeper global collaboration, and building local capacity. By fostering self-reliance, Africa can move beyond aid dependency to become a strategic global partner in health innovation.
Momentum is building as investments in biotech, vaccine manufacturing, and research pave the way for healthcare sovereignty. With the right partnerships, this progress can spark a new era of innovation, resilience, and self-reliance.
At Hayat Biotech, we’re proud to stand alongside governments, institutions, and global partners in advancing this vision for Africa’s healthcare future.
Read the full article here:
https://www.forbesmiddleeast.com/leadership/leaders-insights/naser-al-yammahi-ceo-of-hayat-biotech-partnerships-powering-african-healthcare
